Paul Tudor Jones Says AI Bull Market Has More Room: 2 Stocks to Watch
The AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,259 articlesThe AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...
Investors are eyeing space stocks, but SpaceX remains private while Rocket Lab trades on the public market. This guid...
Berkshire Hathaway made some notable portfolio shifts that surprised many investors. This guide explains what happene...
Investors face a decisive choice: lean into specialized aerospace parts with HEICO or embrace Textron’s diversified i...
Investors often chase certainty, but the loudest promises can hide fragile fundamentals. This guide shows how to spot...
FuelCell Energy priced a $225 million stock offering at $21 per share, triggering a 14% slide and dragging peers Bloo...
As 2027 nears, the latest social security cola forecasts hint at a bigger raise. But higher checks aren’t a guarantee...
As AMC gears up for earnings, investors are asking if the meme-stock buzz can turn into real profits. This article br...
Investors are jittery as AI powerhouses push for faster adoption, while critics warn of overhype. This piece breaks d...
Oil shipments face new risk as Iran signals deployment of sea mines in key chokepoints. Here’s how that could affect ...
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...